These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1593916)

  • 1. Community pharmacists as immunization advocates. Cost-effectiveness of a cue to influenza vaccination.
    Grabenstein JD; Hartzema AG; Guess HA; Johnston WP; Rittenhouse BE
    Med Care; 1992 Jun; 30(6):503-13. PubMed ID: 1593916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.
    Prosser LA; O'Brien MA; Molinari NA; Hohman KH; Nichol KL; Messonnier ML; Lieu TA
    Pharmacoeconomics; 2008; 26(2):163-78. PubMed ID: 18198935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the Effect of a National Pharmacy-Led Influenza Vaccination Voucher Program on Morbidity, Mortality, and Costs.
    Singh T; Taitel M; Loy D; Smith-Ray R
    J Manag Care Spec Pharm; 2020 Jan; 26(1):42-47. PubMed ID: 31880234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National survey of pharmacy-based immunization services.
    Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
    Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot.
    Atkins K; van Hoek AJ; Watson C; Baguelin M; Choga L; Patel A; Raj T; Jit M; Griffiths U
    BMJ Open; 2016 Feb; 6(2):e009739. PubMed ID: 26883237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National community pharmacy NHS influenza vaccination service in Wales: a primary care mixed methods study.
    Evans AM; Wood FC; Carter B
    Br J Gen Pract; 2016 Apr; 66(645):e248-57. PubMed ID: 26965025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
    McConeghy KW; Wing C
    Vaccine; 2016 Jun; 34(30):3463-8. PubMed ID: 27219340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma.
    Teufel RJ; Basco WT; Simpson KN
    J Hosp Med; 2008 Mar; 3(2):134-41. PubMed ID: 18438789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the impact of immunization policies, including the addition of pharmacists as immunizers, on influenza vaccination coverage in Nova Scotia, Canada: 2006 to 2016.
    Isenor JE; O'Reilly BA; Bowles SK
    BMC Public Health; 2018 Jun; 18(1):787. PubMed ID: 29940903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of influenza immunization in adult cancer patients in Taiwan.
    Lin HH; Hsu KL; Ko WW; Yang YC; Chang YW; Yu MC; Chen KT
    Clin Microbiol Infect; 2010 Jun; 16(6):663-70. PubMed ID: 19709066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacy intervention on influenza vaccination acceptance: a systematic literature review and meta-analysis.
    Murray E; Bieniek K; Del Aguila M; Egodage S; Litzinger S; Mazouz A; Mills H; Liska J
    Int J Clin Pharm; 2021 Oct; 43(5):1163-1172. PubMed ID: 34047881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy patron perspectives of community pharmacist administered influenza vaccinations.
    Alsabbagh MW; Church D; Wenger L; Papastergiou J; Raman-Wilms L; Schneider E; Waite N
    Res Social Adm Pharm; 2019 Feb; 15(2):202-206. PubMed ID: 29724679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
    Nichol KL
    Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of community pharmacists advocating immunization on influenza vaccination rates among the elderly.
    Usami T; Hashiguchi M; Kouhara T; Ishii A; Nagata T; Mochizuki M
    Yakugaku Zasshi; 2009 Sep; 129(9):1063-8. PubMed ID: 19721382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis.
    Wateska AR; Nowalk MP; Zimmerman RK; Smith KJ; Lin CJ
    BMC Infect Dis; 2018 Jan; 18(1):52. PubMed ID: 29370768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
    Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
    BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient experiences with influenza immunizations administered by pharmacists.
    Isenor JE; Wagg AC; Bowles SK
    Hum Vaccin Immunother; 2018 Mar; 14(3):706-711. PubMed ID: 29303681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.